PetIQ, Inc. (PETQ)

USD 30.98

(-0.03%)

Total Liabilities Summary of PetIQ, Inc.

  • PetIQ, Inc.'s latest annual total liabilities in 2023 was 645.22 Million USD , up 6.28% from previous year.
  • PetIQ, Inc.'s latest quarterly total liabilities in 2024 Q2 was 634.07 Million USD , down -0.52% from previous quarter.
  • PetIQ, Inc. reported annual total liabilities of 607.1 Million USD in 2022, up 7.57% from previous year.
  • PetIQ, Inc. reported annual total liabilities of 564.36 Million USD in 2021, up 18.17% from previous year.
  • PetIQ, Inc. reported quarterly total liabilities of 637.38 Million USD for 2024 Q1, down -1.22% from previous quarter.
  • PetIQ, Inc. reported quarterly total liabilities of 645.22 Million USD for 2023 Q4, up 4.42% from previous quarter.

Annual Total Liabilities Chart of PetIQ, Inc. (2023 - 2014)

Historical Annual Total Liabilities of PetIQ, Inc. (2023 - 2014)

Year Total Liabilities Total Liabilities Growth
2023 645.22 Million USD 6.28%
2022 607.1 Million USD 7.57%
2021 564.36 Million USD 18.17%
2020 477.57 Million USD 38.66%
2019 344.41 Million USD 97.42%
2018 174.45 Million USD 384.59%
2017 36 Million USD -10.77%
2016 40.34 Million USD -12.4%
2015 46.06 Million USD 105.19%
2014 22.44 Million USD 0.0%

Peer Total Liabilities Comparison of PetIQ, Inc.

Name Total Liabilities Total Liabilities Difference
Collegium Pharmaceutical, Inc. 947.87 Million USD 31.929%
Embecta Corp. 2.03 Billion USD 68.311%
ANI Pharmaceuticals, Inc. 471.67 Million USD -36.796%
Dynavax Technologies Corporation 375.02 Million USD -72.05%
Esperion Therapeutics, Inc. 660.79 Million USD 2.355%
Pacira BioSciences, Inc. 704.25 Million USD 8.382%
PainReform Ltd. 2.69 Million USD -23877.258%
Aquestive Therapeutics, Inc. 163.9 Million USD -293.66%
Sunshine Biopharma, Inc. 6.13 Million USD -10409.284%
SCYNEXIS, Inc. 55.45 Million USD -1063.621%
China SXT Pharmaceuticals, Inc. 9.19 Million USD -6915.932%
Cosmos Health Inc. 30.25 Million USD -2032.807%
Journey Medical Corporation 56.49 Million USD -1042.017%
Sunshine Biopharma, Inc. 6.13 Million USD -10409.284%
Safety Shot Inc 3.89 Million USD -16478.127%
Alpha Teknova, Inc. 38.55 Million USD -1573.7%
Intra-Cellular Therapies, Inc. 136.87 Million USD -371.413%
Bright Green Corporation 6.43 Million USD -9922.022%
Procaps Group, S.A. 462.06 Million USD -39.64%
Theratechnologies Inc. 98.63 Million USD -554.131%
Harrow Health, Inc. 241.75 Million USD -166.896%
Sonoma Pharmaceuticals, Inc. 8.75 Million USD -7268.981%
Biofrontera Inc. 23.13 Million USD -2688.487%
DURECT Corporation 30.4 Million USD -2022.042%
Supernus Pharmaceuticals, Inc. 487.46 Million USD -32.365%
Cronos Group Inc. 43.73 Million USD -1375.276%
OptiNose, Inc. 194.33 Million USD -232.018%
Ironwood Pharmaceuticals, Inc. 817.36 Million USD 21.06%
Kala Pharmaceuticals, Inc. 48.44 Million USD -1231.877%
RedHill Biopharma Ltd. 20.97 Million USD -2975.718%
Organogenesis Holdings Inc. 181.36 Million USD -255.768%
Guardion Health Sciences, Inc. 3.77 Million USD -17005.119%
Cumberland Pharmaceuticals Inc. 52.51 Million USD -1128.626%
Radius Health, Inc. 804.29 Million USD 19.777%
Universe Pharmaceuticals INC 13.75 Million USD -4591.09%
ProPhase Labs, Inc. 42.54 Million USD -1416.613%
Phibro Animal Health Corporation 725.54 Million USD 11.07%
Procaps Group S.A. 462.06 Million USD -39.64%
Alvotech 1.88 Billion USD 65.726%
TherapeuticsMD, Inc. 14.02 Million USD -4501.54%
Viatris Inc. 27.21 Billion USD 97.629%
Rockwell Medical, Inc. 30.88 Million USD -1989.334%
Aytu BioPharma, Inc. 90.37 Million USD -613.914%
SIGA Technologies, Inc. 57.97 Million USD -1012.898%
Tilray Brands, Inc. 892.11 Million USD 27.675%
Lifecore Biomedical, Inc. 219.8 Million USD -193.552%
Shineco, Inc. 47.6 Million USD -1255.473%
Regencell Bioscience Holdings Limited 219.51 Thousand USD -293837.461%
Incannex Healthcare Limited 5.83 Million USD -10967.376%
Neurocrine Biosciences, Inc. 1.01 Billion USD 36.705%
Alimera Sciences, Inc. 107.35 Million USD -501.028%
Silver Spike Investment Corp. 3 Million USD -21337.35%
Assertio Holdings, Inc. 148.41 Million USD -334.743%
Shuttle Pharmaceuticals Holdings, Inc. 1.89 Million USD -33931.641%
Petros Pharmaceuticals, Inc. 21.31 Million USD -2926.998%
Clever Leaves Holdings Inc. 7.02 Million USD -9083.433%
Cyclo Therapeutics, Inc. 8.49 Million USD -7499.383%
Avadel Pharmaceuticals plc 173.38 Million USD -272.132%
Hempacco Co., Inc. 18.82 Million USD -3327.979%
Talphera, Inc. 6.29 Million USD -10157.997%
Alvotech 1.88 Billion USD 65.726%
Eagle Pharmaceuticals, Inc. 172.6 Million USD -273.829%
Lantheus Holdings, Inc. 835.25 Million USD 22.751%
Currenc Group, Inc. 177.67 Million USD -263.149%
Kamada Ltd. 109.96 Million USD -486.74%
Indivior PLC 1.95 Billion USD 66.932%
Evoke Pharma, Inc. 9.64 Million USD -6587.629%
Flora Growth Corp. 17.22 Million USD -3646.534%
Cyclo Therapeutics, Inc. 8.49 Million USD -7499.383%
Evolus, Inc. 209.68 Million USD -207.71%
HUTCHMED (China) Limited 536.38 Million USD -20.292%
Amphastar Pharmaceuticals, Inc. 873.49 Million USD 26.132%
Akanda Corp. 12.66 Million USD -4993.013%